SCALE OF THE PROBLEM: The Health Risks of GLP-1 Inhibitors - This book provides a critical examination of GLP-1 receptor agonists like Ozempic and Wegovy, among others, contrasting their pharmaceutical success with a range of severe health risks and legal challenges. We detail documented complications such as gastroparesis, vision loss, pancreatitis, and more, arguing that manufacturers have downplayed these dangers in their extensive marketing campaigns. Beyond the physical side effects, the source explores the financial motivations behind drug patents and the potential for a "dependency trap" due to rapid weight regain after cessation. Finally, we propose Living Superfood as a means to "Get the Weight Off" safely and permanently. Discounted to $8.99